Hitesh Prabhubhai Dalvadi

Dr. Hitesh Prabhubhai Dalvadi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2019 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
HDHitesh Prabhubhai Dalvadi
Hitesh Prabhubhai Dalvadi
KPKomal Parmar
Komal Parmar
SYSuryabali Yadav
Suryabali Yadav
Bicalutamide (BCT), an anticancer drug, suffers from dissolution rate limited bioavailability and poor micromeritic properties. Spherical crystallization involves formation of spherical agglomerates with enhanced dissolution properties, obviating the need of further granulation process. The present investigation was focused on spherical agglomeration of BCT by quasi emulsion solvent diffusion method. All the responses were subjected to principal component analysis to scrutinize the critical attributes. Further for optimization, X1; influence of phase ratio, X2; amount of PEG 6000 and X3; stirring speed on critical dependent variables was studied by employing the Box-Behken experimental design. The agglomerates exhibited better flow properties, higher bulk density and improved compressibility compared to pure powder drug. In-vitro release studies revealed enhancement of dissolution properties of poorly soluble BCT. Characterization studies carried out by differential scanning calorimeter and powder X-ray diffractometer revealed crystallinity of drug with decreased intensity in the formulation. Scanning electron microscopy showed spherical shape agglomerates of BCT. The residual solvents were largely below the permitted limits. Spherical agglomerates demonstrated enhanced dissolution properties on account of reduced particle size and partial conversion into amorphous form. Thus, spherical agglomerates of BCT seem to be promising approach to ameliorate the dissolution properties which might thereby improve its bioavailability.

1 June 2018 in Bulletin of Faculty of Pharmacy, Cairo University
Verified
Journal Article
Open access
KPKomal Parmar
Komal Parmar
ASAlmas Shaikh
Almas Shaikh
HDHitesh Prabhubhai Dalvadi
Hitesh Prabhubhai Dalvadi

31 March 2026 in Advancements in Ethnobotanical Sciences
Verified
Journal Article
Open access
PDF file
HDHitesh Prabhubhai Dalvadi
Hitesh Prabhubhai Dalvadi
MMMostafa Mahmand
Mostafa Mahmand
Background and Objective: Prostatitis is a common health concern among men, and medicinal plants have long been used in traditional medicine to alleviate symptoms and manage various prostatitis-related conditions. This study aimed to identify and document medicinal plants traditionally used for the prevention and management of prostatitis in Chardavol County, Ilam Province, western Iran. Methods: A descriptive cross-sectional ethnobotanical survey was conducted in Chardavol County, Ilam Province, western Iran. Ethnobotanical data were collected through face-to-face, semi-structured interviews with 30 local knowledgeable informants using purposive and snowball sampling. Information on plant identity, botanical family, plant parts used, preparation and administration methods, and reported traditional uses was recorded. Results: This ethnobotanical survey documented nine plant-use records across seven families traditionally used for prostatitis in Chardavol County. Asteraceae was the most represented family (33.3%, three records). Roots and leaves were the most commonly used plant parts, followed by fruits and aerial parts. Infusion and decoction were the main preparation methods, with infusion being the most frequently reported, used to treat various urinary and prostate-related complaints. Conclusions: The findings document locally transmitted knowledge concerning the traditional use of medicinal plants for prostatitis conditions in Chardavol County. The repeated use of certain species and the predominance of simple aqueous preparations provide useful leads for future ethnobotanical, phytochemical, and pharmacological research. However, traditional reports should not be interpreted as evidence of clinical efficacy. Further phytochemical, pharmacological, toxicological, and well-designed clinical studies are required to evaluate the efficacy and safety of these plants.